Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells

Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells

Comprehensive treatment based on chemotherapy is regarded as the first-line treatment for patients with unresectable or metastatic esophageal squamous cell carcinoma (ESCC). However, chemoresistance is common among patients with ESCC. Therefore, there is a need to explore new therapeutic strategies...

Full description

Bibliographic Details
Main Authors: DANG, LIFENG, WEN, FENGBIAO, YANG, YANG, LIU, DONGLEI, WU, KAI, QI, YU, LI, XIANGNAN, ZHAO, JIA, ZHU, DENGYAN, ZHANG, CHUNYANG, ZHAO, SONG
Format: Online
Language:English
Published: D.A. Spandidos 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020493/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020493/

Similar Items